Form 8-K AMEDISYS INC For: Oct 29

Go back to Form 8-K AMEDISYS INC For: Oct 29

Amedisys (AMED) PT Raised to $126 at RBC Capital

October 31, 2018 6:59 AM EDT

RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $126.00 (from $115.00) while maintaining an Outperform rating.

Morgan noted a strong Q3, with momentum in 2019.

... More